188 related articles for article (PubMed ID: 23494053)
1. Transient heparin-induced platelet activation linked to generation of platelet 12-lipoxygenase. Findings from a randomised controlled trial.
McMahon GS; Jones CI; Hayes PD; Naylor AR; Goodall AH
Thromb Haemost; 2013 Jun; 109(6):1099-107. PubMed ID: 23494053
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight heparin significantly reduces embolisation after carotid endarterectomy--a randomised controlled trial.
McMahon GS; Webster SE; Hayes PD; Jones CI; Goodall AH; Naylor AR
Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):633-9. PubMed ID: 19328023
[TBL] [Abstract][Full Text] [Related]
3. Anti-platelet effect of aspirin is substantially reduced after administration of heparin during carotid endarterectomy.
Webster SE; Payne DA; Jones CI; Hayes PD; Bell PR; Goodall AH; Naylor AR
J Vasc Surg; 2004 Sep; 40(3):463-8. PubMed ID: 15337874
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
Storey RF; May JA; Heptinstall S
Thromb Res; 2005; 115(4):301-7. PubMed ID: 15668190
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
[TBL] [Abstract][Full Text] [Related]
6. Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance?
Payne DA; Jones CI; Hayes PD; Webster SE; Ross Naylor A; Goodall AH
Thromb Haemost; 2004 Jul; 92(1):89-96. PubMed ID: 15213849
[TBL] [Abstract][Full Text] [Related]
7. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic investigation of the anti-platelet aggregation activity of ginsenoside Rk₁ reveals attenuated 12-HETE production.
Ju HK; Lee JG; Park MK; Park SJ; Lee CH; Park JH; Kwon SW
J Proteome Res; 2012 Oct; 11(10):4939-46. PubMed ID: 22873173
[TBL] [Abstract][Full Text] [Related]
9. Platelet 12-lipoxygenase activation via glycoprotein VI: involvement of multiple signaling pathways in agonist control of H(P)ETE synthesis.
Coffey MJ; Jarvis GE; Gibbins JM; Coles B; Barrett NE; Wylie OR; O'Donnell VB
Circ Res; 2004 Jun; 94(12):1598-605. PubMed ID: 15142951
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.
Furman MI; Kereiakes DJ; Krueger LA; Mueller MN; Pieper K; Broderick TM; Schneider JF; Howard WL; Fox ML; Barnard MR; Frelinger AL; Michelson AD
Am Heart J; 2001 Nov; 142(5):790-8. PubMed ID: 11685164
[TBL] [Abstract][Full Text] [Related]
11. [Effect of unfractionated and low-molecular-weight heparin on platelet aggregation and in vitro bleeding time in dogs].
Nimmerfall K; Mischke R
Dtsch Tierarztl Wochenschr; 1999 Oct; 106(10):439-44. PubMed ID: 10589154
[TBL] [Abstract][Full Text] [Related]
12. Combined arachidonic acid and ADP platelet inhibition maximizes patency of small-diameter vascular grafts.
Valentin LI; Sicard GA; Freeman MB; Allen BT; McGoff MA; Anderson CB
Surgery; 1988 Aug; 104(2):178-84. PubMed ID: 3135624
[TBL] [Abstract][Full Text] [Related]
13. Changes in platelet function with inflammation in patients undergoing vascular surgery.
Olechowski B; Khanna V; Mariathas M; Ashby A; Dalton RT; Nordon I; Englyst N; Harris S; Nicholas Z; Thayalasamy K; Mahmoudi M; Curzen N
Platelets; 2019; 30(2):190-198. PubMed ID: 29227173
[TBL] [Abstract][Full Text] [Related]
14. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
[TBL] [Abstract][Full Text] [Related]
15. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
17. Effect of adenine nucleotides on cyclooxygenase and lipoxygenase enzyme products of arachidonic acid in human platelets.
Dragan YP; Ellis EF
Biochem Pharmacol; 1990 Jan; 39(1):27-32. PubMed ID: 2105095
[TBL] [Abstract][Full Text] [Related]
18. Post interventional cardiology urinary thromboxane correlates with PlateletMapping detected aspirin resistance.
Carroll RC; Worthington RE; Craft RM; Snider CC; Dakin PA; Wortham DC; Scott J; Jarrett A
Thromb Res; 2010 Apr; 125(4):e118-22. PubMed ID: 19962724
[TBL] [Abstract][Full Text] [Related]
19. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
[TBL] [Abstract][Full Text] [Related]
20. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling.
Marwali MR; Hu CP; Mohandas B; Dandapat A; Deonikar P; Chen J; Cawich I; Sawamura T; Kavdia M; Mehta JL
J Pharmacol Exp Ther; 2007 Sep; 322(3):1324-32. PubMed ID: 17538005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
